Re-starting the conversation: improving shared decision making in antipsychotic prescribing

References

• Bülow, P., Andersson, G., Denhov, A., & Topor, A. (2016). Experience of psychotropic medication –An interview study of persons with psychosis. Issues in Mental Health Nursing, 37(11), 820–828. https://doi.org/https://doi.org/10.1080/01612840.2016.1224283
   PubMed Web of Science ®Google Scholar
• Burton, A., Osborn, D., Atkins, L., Michie, S., Gray, B., Stevenson, F., Walters, K., & Gilbert, H. (2015). Lowering cardiovascular disease risk for people with severe mental illnesses in primary care: A focus group study. PLoS ONE, 10(8), 1–16. https://doi.org/https://doi.org/10.1371/journal.pone.0136603
   Web of Science ®Google Scholar
• Charles, C., Gafni, A., & Whelan, T. (1999). Decision making in the physician-patient encounter: Revisiting the shared treatment decisionmaking model. Social Science & Medicine, 49(5), 651–661. https://doi.org/https://doi.org/10.4324/9781315013015-30
   PubMed Web of Science ®Google Scholar
• Foley, D. L., & Morley, K. I. (2011). Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Archives of General Psychiatry, 68(6), 609–616. https://doi.org/https://doi.org/10.1001/archgenpsychiatry.2011.2
   PubMed Web of Science ®Google Scholar
• Grim, K., Rosenberg, D., Svedberg, P., & Schön, U. K. (2016). Shared decision-making in mental health care-a user perspective on decisional needs in community-based services. International Journal of Qualitative Studies on Health and Well-Being, 11(1), 1–8. https://doi.org/https://doi.org/10.3402/qhw.v11.30563
   Web of Science ®Google Scholar
• Husa, A. P., Rannikko, I., Moilanen, J., Haapea, M., Murray, G. K., Barnett, J., Jones, P. B., Isohanni, M., Koponen, H., Miettunen, J., & Jääskeläinen, E. (2014). Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia - An observational 9-year follow-up study. Schizophrenia Research, 158(1–3), 134–141. https://doi.org/https://doi.org/10.1016/j.schres.2014.06.035
   PubMed Web of Science ®Google Scholar
• Kendrick, T., Burns, T., & Freeling, P. (1995). Randomised controlled trial of teaching general practitioners to carry out structured assessments of their long term mentally ill patients. Bmj, 311(6997), 93. https://doi.org/https://doi.org/10.1136/bmj.311.6997.93
   PubMedGoogle Scholar
• LeGeyt, G., Awenat, Y., Tai, S., & Haddock, G. (2017). Personal accounts of discontinuing neuroleptic medication for psychosis. Qualitative Health Research, 27(4), 559–572. https://doi.org/https://doi.org/10.1177/1049732316634047
   PubMed Web of Science ®Google Scholar
• Lester, H., Tritter, J. Q., & England, E. (2003). Satisfaction with primary care: The perspectives of people with schizophrenia. Family Practice, 20(5), 508–513. https://doi.org/https://doi.org/10.1093/fampra/cmg502
   PubMed Web of Science ®Google Scholar
• Leucht, S., Arbter, D., Engel, R. R., Kissling, W., & Davis, J. M. (2009). How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Molecular Psychiatry, 14(4), 429–447. https://doi.org/https://doi.org/10.1038/sj.mp.4002136
   PubMed Web of Science ®Google Scholar
• Luykx, J. J., Van Veen, S. M. P., Risselada, A., Naarding, P., Tijdink, J. K., & Vinkers, C. H. (2020). Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic. British Journal of Psychiatry, 217(3), 471–474. https://doi.org/https://doi.org/10.1192/bjp.2020.92
   PubMed Web of Science ®Google Scholar
• Maidment, I. D., Brown, P., & Calnan, M. (2011). An exploratory study of the role of trust in medication management within mental health services. International Journal of Clinical Pharmacy, 33(4), 614–620. https://doi.org/https://doi.org/10.1007/s11096-011-9510-5
   PubMed Web of Science ®Google Scholar
• McDonell, M. G., Kaufman, E. A., Srebnik, D. S., Ciechanowski, P. S., & Ries, R. K. (2011). Barriers to metabolic care for adults with serious mental illness: Provider perspectives. The International Journal of Psychiatry in Medicine, 41(4), 379–387. https://doi.org/https://doi.org/10.2190/PM.41.4.g
   PubMed Web of Science ®Google Scholar
• Mikesell, L., Bromley, E., Young, A. S., Vona, P., & Zima, B. (2016). Integrating client and clinician perspectives on psychotropic medication decisions: Developing a communication-centered epistemic model of shared decision making for mental health contexts. Health Communication, 31(6), 707–717. https://doi.org/https://doi.org/10.1080/10410236.2014.993296
   PubMed Web of Science ®Google Scholar
• Moncrieff, J., Gupta, S., & Horowitz, M. A. (2020). Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder. Therapeutic Advances in Psychopharmacology, 10, 1–10. https://doi.org/https://doi.org/10.1177/2045125320937910
   Web of Science ®Google Scholar
• Morrison, A. P., Hutton, P., Shiers, D., & Turkington, D. (2012). Antipsychotics: Is it time to introduce patient choice? British Journal of Psychiatry, 201(2), 83–84. https://doi.org/https://doi.org/10.1192/bjp.bp.112.112110
   PubMed Web of Science ®Google Scholar
• Murray, R. M., Quattrone, D., Natesan, S., Van Os, J., Nordentoft, M., Howes, O., Di Forti, M., & Taylor, D. (2016). Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics. British Journal of Psychiatry, 209(5), 361–365. https://doi.org/https://doi.org/10.1192/bjp.bp.116182683
   PubMed Web of Science ®Google Scholar
• National Institute of Mental Health [NIHM]. (2016). Mental health medications. National Institute of mental health. https://www.nimh.nih.gov/health/topics/mental-health-medications/index.shtml
   Google Scholar
• Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009). Atypical antipsychotic drugs and the risk of sudden cardiac death. New England Journal of Medicine, 360(20), 2137. https://doi.org/https://doi.org/10.1097/01.sa.0000360612.83083.3e
   PubMedGoogle Scholar
• Read, J., & Sacia, A. (2020). Using open questions to understand 650 people’s experiences with antipsychotic drugs. Schizophrenia Bulletin, 46(4), 896–904. https://doi.org/https://doi.org/10.1093/schbul/sbaa002
   PubMed Web of Science ®Google Scholar
• Royal College of Psychiatrists. (2014). Report of the second round of the national audit of schizophrenia (NAS2) 2014. Royal College of Psychiatrists. http://www.rcpsych.ac.uk/pdf/FINALreportforthesecondroundoftheNationalAuditofSchizophrenia-8.10.14v2.pdf
   Google Scholar
• Royal College of Psychiatrists. (2021). COVID-19: Providing medication. Royal College of Psychiatrists. https://www.rcpsych.ac.uk/about-us/responding-to-covid-19/responding-to-covid-19-guidance-for-clinicians/community-and-inpatient-services/providing-medication
   Google Scholar
• Thompson, J., Stansfeld, J. L., Cooper, R. E., Morant, N., Crellin, N. E., & Moncrieff, J. (2020). Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: A systematic review and thematic synthesis of qualitative data. Social Psychiatry and Psychiatric Epidemiology, 55(2), 151–164. https://doi.org/https://doi.org/10.1007/s00127-019-01819-2
   PubMed Web of Science ®Google Scholar
• Weinmann, S., Read, J., & Aderhold, V. (2009). Influence of antipsychotics on mortality in schizophrenia: Systematic review. Schizophrenia Research, 113(1), 1–11. https://doi.org/https://doi.org/10.1016/j.schres.2009.05.018
   PubMed Web of Science ®Google Scholar